Market Closed - Deutsche Boerse AG 01:10:17 01/06/2024 am IST | ||
867.3 EUR | +0.24% |
1 month | +5.43% | ||
3 months | +3.40% |
Comparison chart between the derivative product and it's underlying value
Latest news about REGENERON PHARMACEUTICALS, INC.
Date | Price | Change |
---|---|---|
31/24/31 | 867.3 | +0.24% |
30/24/30 | 865.2 | -0.27% |
29/24/29 | 867.6 | +0.49% |
28/24/28 | 863.4 | -0.49% |
27/24/27 | 867.6 | -0.02% |
Delayed Quote Deutsche Boerse AG
Last update May 01, 2024 at 01:10 am IST
More quotesStatic data
Product type | Certificats Discount |
---|---|
Buy / Sell | CALL |
Underlying | REGENERON PHARMACEUTICALS, INC. |
Issuer | BNP Paribas |
WKN | PN5D7E |
ISIN | DE000PN5D7E4 |
Date issued | 28/06/2023 |
Cap | 950 $ |
Last trading day | 21/06/2024 |
Maturity | 21/06/2024 (19 Days) |
Parity | 1 : 1 |
Emission price | 679.2 € |
Emission volume | N/A |
Payment day | 27/06/2024 |
Bonus | - € |
Settlement | règlement en espèces |
Currency | EUR |
Technical Indicators
Discount (ask) | 0.000000 % |
---|---|
Sideways yield | 0.000000 % |
Sideways yield pa | 0.000000 % |
Outperformance point | - $ |
Break even | 0.000000 € |
Highest since issue | 869.9 € |
Lowest since issue | 619.8 € |
Distance Cap | 30.16 $ |
Distance Cap % | +3.08% |
Max. earning | - |
Max. earning % | 0.000000 % |
Company Profile
Ratings for Regeneron Pharmaceuticals, Inc.
Consensus: Regeneron Pharmaceuticals, Inc.
- Stock Market
- Certificates
- Certificat